nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimetrexate—DHFR—Methotrexate—multiple sclerosis	0.876	1	CbGbCtD
Trimetrexate—DHFR—Nucleotide Metabolism—SRM—multiple sclerosis	0.00926	0.329	CbGpPWpGaD
Trimetrexate—DHFR—Nucleotide Metabolism—RRM1—multiple sclerosis	0.00494	0.176	CbGpPWpGaD
Trimetrexate—Electrolyte imbalance—Methylprednisolone—multiple sclerosis	0.00353	0.0367	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Fingolimod—multiple sclerosis	0.00343	0.0357	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Fingolimod—multiple sclerosis	0.00336	0.035	CcSEcCtD
Trimetrexate—Electrolyte imbalance—Dexamethasone—multiple sclerosis	0.00321	0.0334	CcSEcCtD
Trimetrexate—Electrolyte imbalance—Betamethasone—multiple sclerosis	0.00321	0.0334	CcSEcCtD
Trimetrexate—Serum creatinine increased—Mitoxantrone—multiple sclerosis	0.00318	0.0331	CcSEcCtD
Trimetrexate—DHFR—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00318	0.113	CbGpPWpGaD
Trimetrexate—Blood bilirubin increased—Cladribine—multiple sclerosis	0.00315	0.0328	CcSEcCtD
Trimetrexate—Hepatotoxicity—Azathioprine—multiple sclerosis	0.00313	0.0326	CcSEcCtD
Trimetrexate—Hypocalcaemia—Mitoxantrone—multiple sclerosis	0.00214	0.0222	CcSEcCtD
Trimetrexate—Blood bilirubin increased—Mitoxantrone—multiple sclerosis	0.00207	0.0215	CcSEcCtD
Trimetrexate—Neutropenia—Cladribine—multiple sclerosis	0.00175	0.0182	CcSEcCtD
Trimetrexate—DHFR—E2F transcription factor network—RRM1—multiple sclerosis	0.00168	0.0598	CbGpPWpGaD
Trimetrexate—Fatigue—Fingolimod—multiple sclerosis	0.00161	0.0168	CcSEcCtD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.00146	0.052	CbGpPWpGaD
Trimetrexate—Hyponatraemia—Mitoxantrone—multiple sclerosis	0.00143	0.0148	CcSEcCtD
Trimetrexate—Asthenia—Fingolimod—multiple sclerosis	0.00134	0.014	CcSEcCtD
Trimetrexate—Blood creatinine increased—Mitoxantrone—multiple sclerosis	0.00133	0.0139	CcSEcCtD
Trimetrexate—Pruritus—Fingolimod—multiple sclerosis	0.00133	0.0138	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Mitoxantrone—multiple sclerosis	0.00128	0.0133	CcSEcCtD
Trimetrexate—Hepatotoxicity—Methotrexate—multiple sclerosis	0.00126	0.0131	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Mitoxantrone—multiple sclerosis	0.00125	0.013	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Methylprednisolone—multiple sclerosis	0.00123	0.0128	CcSEcCtD
Trimetrexate—Anaemia—Cladribine—multiple sclerosis	0.0012	0.0125	CcSEcCtD
Trimetrexate—Neutropenia—Mitoxantrone—multiple sclerosis	0.00115	0.0119	CcSEcCtD
Trimetrexate—Confusional state—Cladribine—multiple sclerosis	0.00107	0.0111	CcSEcCtD
Trimetrexate—Thrombocytopenia—Cladribine—multiple sclerosis	0.00104	0.0108	CcSEcCtD
Trimetrexate—Anaemia—Azathioprine—multiple sclerosis	0.000978	0.0102	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Methylprednisolone—multiple sclerosis	0.000943	0.00982	CcSEcCtD
Trimetrexate—Fatigue—Cladribine—multiple sclerosis	0.000915	0.00953	CcSEcCtD
Trimetrexate—Feeling abnormal—Cladribine—multiple sclerosis	0.000875	0.00911	CcSEcCtD
Trimetrexate—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000845	0.0088	CcSEcCtD
Trimetrexate—Body temperature increased—Cladribine—multiple sclerosis	0.000839	0.00874	CcSEcCtD
Trimetrexate—Anaemia—Mitoxantrone—multiple sclerosis	0.00079	0.00823	CcSEcCtD
Trimetrexate—Asthenia—Cladribine—multiple sclerosis	0.000762	0.00793	CcSEcCtD
Trimetrexate—Pruritus—Cladribine—multiple sclerosis	0.000751	0.00782	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Prednisone—multiple sclerosis	0.000747	0.00777	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—IL4—multiple sclerosis	0.000746	0.0265	CbGpPWpGaD
Trimetrexate—Convulsion—Mitoxantrone—multiple sclerosis	0.000741	0.00771	CcSEcCtD
Trimetrexate—Feeling abnormal—Azathioprine—multiple sclerosis	0.000711	0.00741	CcSEcCtD
Trimetrexate—Confusional state—Mitoxantrone—multiple sclerosis	0.000704	0.00733	CcSEcCtD
Trimetrexate—Neutropenia—Prednisone—multiple sclerosis	0.000684	0.00712	CcSEcCtD
Trimetrexate—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000683	0.00711	CcSEcCtD
Trimetrexate—Body temperature increased—Azathioprine—multiple sclerosis	0.000683	0.00711	CcSEcCtD
Trimetrexate—Vomiting—Cladribine—multiple sclerosis	0.000675	0.00703	CcSEcCtD
Trimetrexate—Rash—Cladribine—multiple sclerosis	0.000669	0.00697	CcSEcCtD
Trimetrexate—Dermatitis—Cladribine—multiple sclerosis	0.000669	0.00696	CcSEcCtD
Trimetrexate—Nausea—Cladribine—multiple sclerosis	0.000631	0.00657	CcSEcCtD
Trimetrexate—Convulsion—Prednisolone—multiple sclerosis	0.000608	0.00633	CcSEcCtD
Trimetrexate—Fatigue—Mitoxantrone—multiple sclerosis	0.000602	0.00626	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—ICAM1—multiple sclerosis	0.000593	0.021	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000575	0.00599	CcSEcCtD
Trimetrexate—Neutropenia—Methotrexate—multiple sclerosis	0.000572	0.00595	CcSEcCtD
Trimetrexate—Convulsion—Triamcinolone—multiple sclerosis	0.000559	0.00582	CcSEcCtD
Trimetrexate—Convulsion—Methylprednisolone—multiple sclerosis	0.000558	0.00581	CcSEcCtD
Trimetrexate—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000552	0.00574	CcSEcCtD
Trimetrexate—Vomiting—Azathioprine—multiple sclerosis	0.000549	0.00572	CcSEcCtD
Trimetrexate—Rash—Azathioprine—multiple sclerosis	0.000544	0.00567	CcSEcCtD
Trimetrexate—Dermatitis—Azathioprine—multiple sclerosis	0.000544	0.00566	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—CCL2—multiple sclerosis	0.00053	0.0188	CbGpPWpGaD
Trimetrexate—Confusional state—Methylprednisolone—multiple sclerosis	0.00053	0.00552	CcSEcCtD
Trimetrexate—Nausea—Azathioprine—multiple sclerosis	0.000513	0.00534	CcSEcCtD
Trimetrexate—Convulsion—Dexamethasone—multiple sclerosis	0.000507	0.00528	CcSEcCtD
Trimetrexate—Convulsion—Betamethasone—multiple sclerosis	0.000507	0.00528	CcSEcCtD
Trimetrexate—Asthenia—Mitoxantrone—multiple sclerosis	0.000501	0.00521	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—ALB—multiple sclerosis	0.000494	0.0175	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Prednisolone—multiple sclerosis	0.000472	0.00491	CcSEcCtD
Trimetrexate—Anaemia—Prednisone—multiple sclerosis	0.000471	0.00491	CcSEcCtD
Trimetrexate—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000468	0.00487	CcSEcCtD
Trimetrexate—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000468	0.00487	CcSEcCtD
Trimetrexate—Fatigue—Triamcinolone—multiple sclerosis	0.000454	0.00473	CcSEcCtD
Trimetrexate—Fatigue—Methylprednisolone—multiple sclerosis	0.000453	0.00472	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—IFNG—multiple sclerosis	0.000451	0.016	CbGpPWpGaD
Trimetrexate—Vomiting—Mitoxantrone—multiple sclerosis	0.000444	0.00462	CcSEcCtD
Trimetrexate—Convulsion—Prednisone—multiple sclerosis	0.000442	0.0046	CcSEcCtD
Trimetrexate—Rash—Mitoxantrone—multiple sclerosis	0.00044	0.00458	CcSEcCtD
Trimetrexate—Dermatitis—Mitoxantrone—multiple sclerosis	0.00044	0.00458	CcSEcCtD
Trimetrexate—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000434	0.00452	CcSEcCtD
Trimetrexate—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000433	0.00451	CcSEcCtD
Trimetrexate—Body temperature increased—Triamcinolone—multiple sclerosis	0.000416	0.00433	CcSEcCtD
Trimetrexate—Nausea—Mitoxantrone—multiple sclerosis	0.000415	0.00432	CcSEcCtD
Trimetrexate—Fatigue—Betamethasone—multiple sclerosis	0.000412	0.00429	CcSEcCtD
Trimetrexate—Fatigue—Dexamethasone—multiple sclerosis	0.000412	0.00429	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—IL1B—multiple sclerosis	0.000402	0.0143	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—IL2—multiple sclerosis	0.000401	0.0142	CbGpPWpGaD
Trimetrexate—Anaemia—Methotrexate—multiple sclerosis	0.000394	0.0041	CcSEcCtD
Trimetrexate—Feeling abnormal—Betamethasone—multiple sclerosis	0.000394	0.0041	CcSEcCtD
Trimetrexate—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000394	0.0041	CcSEcCtD
Trimetrexate—Asthenia—Triamcinolone—multiple sclerosis	0.000378	0.00393	CcSEcCtD
Trimetrexate—Body temperature increased—Dexamethasone—multiple sclerosis	0.000378	0.00393	CcSEcCtD
Trimetrexate—Body temperature increased—Betamethasone—multiple sclerosis	0.000378	0.00393	CcSEcCtD
Trimetrexate—Asthenia—Methylprednisolone—multiple sclerosis	0.000377	0.00392	CcSEcCtD
Trimetrexate—Pruritus—Triamcinolone—multiple sclerosis	0.000373	0.00388	CcSEcCtD
Trimetrexate—Pruritus—Methylprednisolone—multiple sclerosis	0.000372	0.00387	CcSEcCtD
Trimetrexate—Convulsion—Methotrexate—multiple sclerosis	0.000369	0.00384	CcSEcCtD
Trimetrexate—Rash—Prednisolone—multiple sclerosis	0.000361	0.00376	CcSEcCtD
Trimetrexate—Dermatitis—Prednisolone—multiple sclerosis	0.000361	0.00376	CcSEcCtD
Trimetrexate—Fatigue—Prednisone—multiple sclerosis	0.000359	0.00373	CcSEcCtD
Trimetrexate—Confusional state—Methotrexate—multiple sclerosis	0.000351	0.00365	CcSEcCtD
Trimetrexate—Feeling abnormal—Prednisone—multiple sclerosis	0.000343	0.00357	CcSEcCtD
Trimetrexate—Asthenia—Dexamethasone—multiple sclerosis	0.000343	0.00357	CcSEcCtD
Trimetrexate—Asthenia—Betamethasone—multiple sclerosis	0.000343	0.00357	CcSEcCtD
Trimetrexate—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00034	0.00354	CcSEcCtD
Trimetrexate—Nausea—Prednisolone—multiple sclerosis	0.00034	0.00354	CcSEcCtD
Trimetrexate—Pruritus—Dexamethasone—multiple sclerosis	0.000338	0.00352	CcSEcCtD
Trimetrexate—Pruritus—Betamethasone—multiple sclerosis	0.000338	0.00352	CcSEcCtD
Trimetrexate—Vomiting—Triamcinolone—multiple sclerosis	0.000335	0.00349	CcSEcCtD
Trimetrexate—Vomiting—Methylprednisolone—multiple sclerosis	0.000334	0.00348	CcSEcCtD
Trimetrexate—Rash—Triamcinolone—multiple sclerosis	0.000332	0.00346	CcSEcCtD
Trimetrexate—Dermatitis—Triamcinolone—multiple sclerosis	0.000332	0.00345	CcSEcCtD
Trimetrexate—Rash—Methylprednisolone—multiple sclerosis	0.000331	0.00345	CcSEcCtD
Trimetrexate—Dermatitis—Methylprednisolone—multiple sclerosis	0.000331	0.00345	CcSEcCtD
Trimetrexate—Body temperature increased—Prednisone—multiple sclerosis	0.000329	0.00342	CcSEcCtD
Trimetrexate—Nausea—Triamcinolone—multiple sclerosis	0.000313	0.00326	CcSEcCtD
Trimetrexate—Nausea—Methylprednisolone—multiple sclerosis	0.000312	0.00325	CcSEcCtD
Trimetrexate—Vomiting—Betamethasone—multiple sclerosis	0.000304	0.00316	CcSEcCtD
Trimetrexate—Vomiting—Dexamethasone—multiple sclerosis	0.000304	0.00316	CcSEcCtD
Trimetrexate—Rash—Betamethasone—multiple sclerosis	0.000301	0.00314	CcSEcCtD
Trimetrexate—Rash—Dexamethasone—multiple sclerosis	0.000301	0.00314	CcSEcCtD
Trimetrexate—Dermatitis—Dexamethasone—multiple sclerosis	0.000301	0.00313	CcSEcCtD
Trimetrexate—Dermatitis—Betamethasone—multiple sclerosis	0.000301	0.00313	CcSEcCtD
Trimetrexate—Fatigue—Methotrexate—multiple sclerosis	0.0003	0.00312	CcSEcCtD
Trimetrexate—Asthenia—Prednisone—multiple sclerosis	0.000299	0.00311	CcSEcCtD
Trimetrexate—Pruritus—Prednisone—multiple sclerosis	0.000294	0.00306	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—TNF—multiple sclerosis	0.000292	0.0104	CbGpPWpGaD
Trimetrexate—DHFR—E2F transcription factor network—MYC—multiple sclerosis	0.000289	0.0103	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Methotrexate—multiple sclerosis	0.000287	0.00298	CcSEcCtD
Trimetrexate—Nausea—Dexamethasone—multiple sclerosis	0.000284	0.00295	CcSEcCtD
Trimetrexate—Nausea—Betamethasone—multiple sclerosis	0.000284	0.00295	CcSEcCtD
Trimetrexate—Body temperature increased—Methotrexate—multiple sclerosis	0.000275	0.00286	CcSEcCtD
Trimetrexate—DHFR—Metabolism—SRM—multiple sclerosis	0.000272	0.00965	CbGpPWpGaD
Trimetrexate—Vomiting—Prednisone—multiple sclerosis	0.000265	0.00275	CcSEcCtD
Trimetrexate—Rash—Prednisone—multiple sclerosis	0.000262	0.00273	CcSEcCtD
Trimetrexate—Dermatitis—Prednisone—multiple sclerosis	0.000262	0.00273	CcSEcCtD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	0.000251	0.00892	CbGpPWpGaD
Trimetrexate—Asthenia—Methotrexate—multiple sclerosis	0.000249	0.0026	CcSEcCtD
Trimetrexate—Nausea—Prednisone—multiple sclerosis	0.000247	0.00257	CcSEcCtD
Trimetrexate—Pruritus—Methotrexate—multiple sclerosis	0.000246	0.00256	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—IL6—multiple sclerosis	0.000236	0.00836	CbGpPWpGaD
Trimetrexate—Vomiting—Methotrexate—multiple sclerosis	0.000221	0.0023	CcSEcCtD
Trimetrexate—Rash—Methotrexate—multiple sclerosis	0.000219	0.00228	CcSEcCtD
Trimetrexate—Dermatitis—Methotrexate—multiple sclerosis	0.000219	0.00228	CcSEcCtD
Trimetrexate—DHFR—G1/S Transition—MYC—multiple sclerosis	0.00021	0.00745	CbGpPWpGaD
Trimetrexate—DHFR—Disease—GPC5—multiple sclerosis	0.000209	0.00743	CbGpPWpGaD
Trimetrexate—Nausea—Methotrexate—multiple sclerosis	0.000207	0.00215	CcSEcCtD
Trimetrexate—DHFR—Metabolism—CYP27B1—multiple sclerosis	0.000191	0.0068	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYP24A1—multiple sclerosis	0.000191	0.0068	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—MYC—multiple sclerosis	0.000177	0.00628	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GPC5—multiple sclerosis	0.000175	0.00622	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—RRM1—multiple sclerosis	0.000145	0.00515	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RPL5—multiple sclerosis	0.000136	0.00483	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SLC11A1—multiple sclerosis	0.00013	0.00463	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CD28—multiple sclerosis	0.000104	0.00369	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—BCHE—multiple sclerosis	8.34e-05	0.00296	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CD86—multiple sclerosis	7.42e-05	0.00264	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CCR5—multiple sclerosis	6.58e-05	0.00234	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—MYC—multiple sclerosis	6.48e-05	0.0023	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HLA-A—multiple sclerosis	6.41e-05	0.00228	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	6.34e-05	0.00225	CbGpPWpGaD
Trimetrexate—DHFR—Disease—APOE—multiple sclerosis	5.99e-05	0.00213	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—MYC—multiple sclerosis	5.8e-05	0.00206	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—MAPK1—multiple sclerosis	5.67e-05	0.00201	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CD80—multiple sclerosis	5.41e-05	0.00192	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—APOE—multiple sclerosis	5.01e-05	0.00178	CbGpPWpGaD
Trimetrexate—DHFR—Disease—TYK2—multiple sclerosis	4.57e-05	0.00162	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—POMC—multiple sclerosis	4.31e-05	0.00153	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CD4—multiple sclerosis	4.13e-05	0.00147	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ALB—multiple sclerosis	3.93e-05	0.00139	CbGpPWpGaD
Trimetrexate—DHFR—Disease—STAT3—multiple sclerosis	3.2e-05	0.00114	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MYC—multiple sclerosis	2.97e-05	0.00106	CbGpPWpGaD
Trimetrexate—DHFR—Disease—TGFB1—multiple sclerosis	2.97e-05	0.00105	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MAPK1—multiple sclerosis	2.91e-05	0.00103	CbGpPWpGaD
Trimetrexate—DHFR—Disease—IL6—multiple sclerosis	2.24e-05	0.000794	CbGpPWpGaD
